Prevention of restenosis after angioplasty in small coronary arteries with probucol

Circulation

Volumn 97, Issue 5, 1998, Pages 429-436

  Rodés, Josep ^b   Côté, Gilles ^b   Lespérance, Jacques ^b   Bourassa, Martial G ^b   Doucet, Serge ^b   Bilodeau, Luc ^b   Bertrand, Olivier F ^b   Harel, François ^b   Gallo, Richard ^b   Tardif, Jean Claude ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b NONE

Author keywords

Angioplasty; Antioxidants; Restenosis

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; MULTIVITAMIN; PROBUCOL;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; VITAMIN INTAKE;

EID: 0345628014     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.5.429     Document Type: Article

References (46)

1. Landau C, Lange RA, Hillis LD. Percutaneous transluminal coronary angioplasty. N Engl J Med. 1994;330:981-993.
2. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Mateme P, Belardi J, Sigwart U, Colombo A, Goy JJ, vd Heuvel P, Delcan J, Morel MA, for the Benestent Study Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
3. Fischman DL, Leon MB, Baim DS, Schatz R, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish D, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
4. Mak KH, Belli G, Ellis SG, Moliterno DJ. Subacute stent thrombosis: evolving issues and current concepts. J Am Coll Cardiol. 1996;27:494-503.
5. Serra A, Massotti M, Fernandez-Avilés F, Alonso J, Colman T, Zueco J, Delcan J, Garcia E, Gimeno F, Calabuig J, Betriu A. Stent versus Angioplasty Restenosis Trial (START): influence of vessel size on angiographic restenosis. Circulation. 1996;94(suppl I):I-93. Abstract.
6. Savage M, Fishman D, Rake R, Schatz R, Penn I, Nobuyoshi M, Moses J, Heuser R, Gebhardt S, Goldberg S, for the STRESS Trial Investigators. Elective coronary stenting versus balloon angioplasty in smaller native coronary arteries: results from STRESS. J Am Coll Cardiol 1996;27:253A. Abstract.
7. Nunes G, Pinto I, Mattos L, Feres F, Chaves A, Tanajura L, Centemero M, Abizaid AC, Sousa A, Sousa JE. Coronary stent implantation in vessels smaller than 3 mm is associated with higher restenosis rates. Eur Heart J. 1996;17:173. Abstract.
8. Keane D, Azar AJ, Serruys PW, Macaya C, Rutsch W, Sigwart U, Colombo A, Marco J, Klugmann S, Crean P, on behalf of the BENESTENT investigators. Outcome following elective stent implantation in small coronary arteries. Eur Heart J. 1995;16:335. Abstract.
9. Chan CN, Tan AT, Koh TH, Koh P, Lau KW, Gunawan SA, Chakraborty B, Ng A. Intracoronary stenting in the treatment of acute or threatened closure in angiographically small coronary arteries (<3 mm) complicating percutaneous transluminal coronary angioplasty. Am J Cardiol. 1995;75:23-25.
10. Dean LS, Zidar JP, Voorhees WD, Holmes DR, O'Shaughnessy CD, Moore PB, Rogers EW, Heuser RR, Roubin GS, Leon MB, for the Cook GRII investigators. Stenting in small vessels: a re-evaluation using the GRII intracoronary stent in a multicenter registry study. J Am Coll Cardiol. 1997;29:396A. Abstract.
11. Morice MC, Valeix B, Bradai R, Dumas P, Louvard Y, Lefevre T, Labrunie P. Coronary stenting of small coronary arteries: preliminary results of a pilot study with the 2.5 mm Microstent AVE. J Am Coll Cardiol. 1997;29:16A. Abstract.
12. Romero M, Suarez de Lezo JS, Medina A, Pan M, Hernandez E, Segura J, Melian F, Ruiz M, Zayas R, Ortega JF. Elective stenting for the treatment of lesion located in small coronary arteries. Eur Heart J. 1996;17:217. Abstract.
13. Azar AJ, Detre K, Goldberg S, Kiemeneij F, Leon MB, Serruys PW, on behalf of the Benestent and Stent Restenosis Study. A meta-analysis on the clinical and angiographic outcomes of stents versus PTCA in the different coronary vessel sizes in the Benestent-1 and Stress-1/2 trials. Circulation. 1995;92(suppl I):I-475. Abstract.
14. Wong C, Hirshfeld J, Teirstein P, Schatz R, Shaknovich A, Nobuyoshi M, Satler LF, Chuang YC, Leon MB. Differential impact of stent vs PTCA on restenosis in large (≥3 mm) and small (<3 mm) vessels in the Stent REStenosis study. J Am Coll Cardiol. 1995;25:375A. Abstract.
15. Tardif JC, Côté G, Lespérance J, Bourassa M, Lambert J, Doucet S, Bilodeau L, Nattel S, de Guise P, for the MVP study group. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med. 1997;337:365-372.
16. Reiber HCJ, Van der Zwet V, Von Land D, Koning G, Meurs BV, Buis B, Voorthuisen EV. Quantitative coronary arteriography: equipment and technical requirements. Reiber JHC, Serruys PW, eds. Advances in Quantitative Coronary Arteriography. Netherlands: Kluwer Academic Publishers; 1993:75-111.
17. Lespérance J, Waters D. Measuring progression and regression of coronary atherosclerosis in clinical trials: problems and progress. Int J Card Imaging. 1992;8:165-173.
18. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
19. Hirshfeld JW, Schwartz JS, Jugo R, Macdonald RG, Goldberg S, Savage MP, Bass TA, Vetrovec G, Cowley M, Taussig AS, Whitworth HB, Margolis JR, Hill JA, Pepine CJ, and the M-HEART Investigators. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Cell Cardiol. 1991;18:647-656.
20. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang YC, Griffin J, Leon MB. Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. J Am Coll Cardiol. 1996;27:1678-1687.
21. Hermans WRM, Rensing BJ, Kelder JC, Feyter PJ, Serruys PW. Postangioplasty restenosis rate between segments of the major coronary arteries. Am J Cardiol. 1992;69:194-200.
22. Rensing BJ, Hermans WRM, Vos J, Tijssen JGP, Rutch W, Danchin N, Heyndrickx GR, Mast EG, Wijns W, Serruys PW, on behalf of the Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group. Luminal narrowing after percutaneous transluminal coronary angioplasty: a study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Circulation. 1993;88:975-985.
23. Foley DP, Melkert R, Serruys PW, on behalf of the CARPORT, MERCATOR, MARCATOR, and PARK Investigators. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation. 1994;90:1239-1251.
24. George BS, Voorhees WD III, Roubin GS, Fearnot NE, Pinkerton CA, Raizner AE, King SB, Holmes DR, Topol EJ, Keriakes DJ, Hartzler GO. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcome. J Am Coll Cardiol. 1993;22:135-143.
25. Roubin GS, Cannon AD, Agrawal SK, Macander PJ, Dean LS, Baxley WA, Breland J. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation. 1992;85:916-927.
26. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis JM. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 1995;91:1676-1688.
27. Bilodeau L, Doucet S, Côté G, Tardif JC, Bonan R, Bertrand OF. Can quantitative coronary analysis replace intravascular ultrasound to assess optimal stent deployment? J Am Coll Cardiol. 1996;27:305A. Abstract.
28. Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Hashida K. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty. Am Heart J. 1996;132:23-29.
29. Setsuda M, Inden M, Hiraoka N, Okamoto S, Tanaka H, Okinaka T, Nishimura Y, Okano H, Kouji T, Konishi T, Nakano T. Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty. Clin Ther. 1993;15:374-381.
30. Yokoi H, Yamaguchi H, Kuwabara Y, for the PART group. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty: Probucol Angioplasty Restenosis Trial (PART). J Am Coll Cardiol. 1996;27:391A. Abstract.
31. Lee YJ, Yamaguchi M, Daida M, Yokoi H, Miyano H, Takaya J, Sakurai H, Noma A. Pharmacological interventions to modify restenosis. Circulation. 1991;84(suppl II):II-299. Abstract.
32. Yokoi H, Daida H, Yamaguchi H, Kuwabara Y, for the PART group. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty in small sized coronary arteries: a subgroup analysis of the Probucol Angioplasty Restenosis Trial (PART). J Am Coll Cardiol. 1997;29:418A. Abstract.
33. Steinberg D. Studies on the mechanism of action of probucol. Am J Cardiol. 1986;57:16H-21H.
34. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344:160-162.
35. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witzum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
36. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 1994;75:650-658.
37. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol. 1995;25:516-520.
38. Langille BL, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science. 1986;231:405-407.
39. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995;332:488-493.
40. Kuzuya M, Naito M, Funaki C, Hayashi T, Asai K, Kuzuya F. Probucol prevents oxidative injury to endothelial cells. J Lipid Res. 1991;32:197-204.
41. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest. 1986;77:641-644.
42. Schneider JE, Berk BC, Gravanis MB, Santoian EC, Cipolla GD, Tarazona N, Lassegue B, King SB III. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury: a possible role for antioxidants in restenosis. Circulation. 1993;88:628-637.
43. Nunes GL, Sgoutas DS, Redden RA, Sigman S, Gravanis MB, King SB III, Berk BC. Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Van Biol. 1995;15:156-165.
44. Weintraub WS, Boccuzzi SJ, Klein L, Kosinski AS, King SB III. Ivanhoe R, Cedarholm JC, Stillabower ME, Talley JD, DeMaio SJ, O'Neill WW, Fraizer JE II, Cohen-Bernstein CL, Robbins DC, Brown CL III, Alexander RW, and the Lovastatin Restenosis Trial Study Group. Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med. 1994;331:1331-1337.
45. Ku G, Doherty NS, Wolos JA, Jackson RL, Schmidt LF, Hendricks D. Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis. Am J Cardiol. 1988;62:77B-81B.
46. Galis ZS, Muszynski M, Sukhova G, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.